Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Searching for optimal dose-volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer.

Faria S, Joshua B, Patrocinio H, Dal Pra A, Cury F, Velly AM, Souhami L.

Clin Oncol (R Coll Radiol). 2010 Dec;22(10):810-7. doi: 10.1016/j.clon.2010.08.005. Epub 2010 Oct 25.

PMID:
20980135
2.

Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.

Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):141-9.

PMID:
16111582
3.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. Review.

PMID:
16029785
4.

Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.

Yeoh EE, Fraser RJ, McGowan RE, Botten RJ, Di Matteo AC, Roos DE, Penniment MG, Borg MF.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):943-55.

PMID:
12605972
5.

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.

Zapatero A, García-Vicente F, Modolell I, Alcántara P, Floriano A, Cruz-Conde A, Torres JJ, Pérez-Torrubia A.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1343-51.

PMID:
15275719
6.

Rectal dose constraints for intensity modulated radiation therapy of the prostate.

Swanson GP, Stathakis S.

Am J Clin Oncol. 2011 Apr;34(2):188-95. doi: 10.1097/COC.0b013e3181dbb993. Review.

PMID:
20622649
8.

Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.

Akimoto T, Muramatsu H, Takahashi M, Saito J, Kitamoto Y, Harashima K, Miyazawa Y, Yamada M, Ito K, Kurokawa K, Yamanaka H, Nakano T, Mitsuhashi N, Niibe H.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1033-9.

PMID:
15519772
9.

Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer.

Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Pickett B, Hsu IC, Speight J, Roach M 3rd.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):69-77. doi: 10.1016/j.ijrobp.2007.12.045. Epub 2008 Mar 14. Review.

PMID:
18342454
10.

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.

Skwarchuk MW, Jackson A, Zelefsky MJ, Venkatraman ES, Cowen DM, Levegrün S, Burman CM, Fuks Z, Leibel SA, Ling CC.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):103-13.

PMID:
10758311
11.
12.

Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.

Greco C, Mazzetta C, Cattani F, Tosi G, Castiglioni S, Fodor A, Orecchia R.

Radiother Oncol. 2003 Nov;69(2):215-22.

PMID:
14643961
13.

Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

Fiorino C, Sanguineti G, Cozzarini C, Fellin G, Foppiano F, Menegotti L, Piazzolla A, Vavassori V, Valdagni R.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):953-62.

PMID:
14575825
15.

[Prostatic carcinoma: problems in the interpretation of rectal dose-volume histograms].

Geinitz H, Zimmermann FB, Narkwong L, Kneschaurek P, Wehrmann R, Kuzmany A, Molls M.

Strahlenther Onkol. 2000 Apr;176(4):168-72. German.

PMID:
10812389
16.

Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate cancer.

Gokhale AS, Beriwal S, Smith RP, Li X, Benoit R.

Brachytherapy. 2010 Oct-Dec;9(4):328-34. doi: 10.1016/j.brachy.2009.09.006. Epub 2010 Jan 29.

PMID:
20116341
17.

Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.

Wachter S, Gerstner N, Goldner G, Pötzi R, Wambersie A, Pötter R.

Radiother Oncol. 2001 Apr;59(1):65-70.

PMID:
11295208
18.

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1314-21.

PMID:
12459352
19.

Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions.

Fiorino C, Cozzarini C, Vavassori V, Sanguineti G, Bianchi C, Cattaneo GM, Foppiano F, Magli A, Piazzolla A.

Radiother Oncol. 2002 Jul;64(1):1-12.

PMID:
12208568
20.

Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy.

Dale E, Olsen DR, Fosså SD.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):385-91.

PMID:
10030266

Supplemental Content

Support Center